4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001213900-20-029412
CEO and CFO bought 16,667 shares at $4.60 ($76,710)
From the SEC's structured data for this filing
Trades in this filing
Patel Snehal · CEO and CFO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-09-29 | Purchase : show line 1 in the form | +16,667 | $4.60 | $76,710 | 1,184,839 | D |
| Open-market purchases · 16,667 sh · avg $4.60 · $76,710 | ||||||
Loading xslF345X03/ownership.xml…